Titan Pharmaceuticals, Inc.
Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases. It develops products based on ProNeura, a proprietary long-term drug delivery platform that focuses primarily on the treatment for chronic diseases. The company offers Probuphine implant for the maintenance treatment of opioid use disorder in clinically stable patients in Canada and the European Union. It is also developing kappa opioid agonist peptide program, TP-2021 for use in combination with ProNeura technology for treatment of chronic pruritus; nalmefene implant program for the prevention of opioid relapse following detoxification of patients suffering opioid use disorder; and other programs, including non-clinical evaluation of the ProNeura platform in malaria prophylaxis. Titan Pharmaceuticals, Inc. was incorporated in 1992 and is based in South San Francisco, California. Show More...
-
Website http://www.titanpharm.com
-
Sector Healthcare
-
Industry Biotechnology
-
Last Quote 4.60 USD
-
Last Updated 30-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share USD -2.97 -9.24 -7.59 3.18 -1.2 -3.36 1.2 -4.22 -1.66 -0.72 -0.45 Dividends USD Payout Ratio % * Shares Mil 2.0 2.0 2.0 3.0 3.0 3.0 4.0 4.0 6.0 23.0 40.0 Book Value Per Share * USD -3.37 -9.75 -10.15 0.38 1.28 2.67 4.32 1.14 0.42 -0.05 0.06 Free Cash Flow Per Share * USD -2.61 -8.52 0.34 0.57 -2.41 -2.21 1.93 -3.33 -2.54 -0.78 Return on Assets % -131.94 -203.13 -86.63 44.91 -12.24 -66.08 32.14 -103.78 -80.94 -139.37 -141.89 Financial Leverage (Average) 3.2 2.42 1.9 1.42 10.39 2.06 6.64 2.51 Return on Equity % -33.44 -144.59 50.89 -203.69 -242.14 -398.31 -420.72 Return on Invested Capital % -33.44 -144.59 50.89 -105.14 -100.16 -193.41 -195.54 Interest Coverage -1.63 -2.12 Current Ratio 0.87 1.94 1.1 1.55 2.94 2.52 3.67 1.86 3.85 2.31 2.75 Quick Ratio 0.81 1.78 1.06 1.53 2.92 2.49 3.62 1.7 3.22 1.73 2.17 Debt/Equity 4.18 0.55 2.91 0.68